MetaTOC stay on top of your field, easily

Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel disease

, , ,

Therapeutic Advances in Gastroenterology

Published online on

Abstract

Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Inflammatory bowel disease (IBD) is a chronic autoimmune condition of the gut caused by an inappropriate reaction towards commensal bacteria by immune cells that reside within the gut-associated lymphoid tissue. IBD is of rising concern due to increased ...